Dividends and Recognitions Affirming Strong Returns to Shareholders- Research Report on Merck, AbbVie, HealthSouth, Quintiles, and Ensign

NEW YORK, September 25, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Investors' Reports announced new research reports highlighting Merck & Co. Inc. (NYSE: MRK), AbbVie Inc. (NYSE: ABBV), HEALTHSOUTH Corp. (NYSE: HLS), Quintiles Transnational Holdings Inc. (NYSE: Q), and The Ensign Group, Inc. (NASDAQ: ENSG). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Merck & Co. Inc. Research Report

On September 17, 2013, Merck & Co. (Merck) announced that it has been recognized as one of the Working Mother 100 Best Companies for 2013, for the 26th year. The Company informed that it has been selected in the list for its commitment to progressive workplace programs, including female representation, compensation, child care, flexibility, time off and leave, family-friendly programs, and company culture. Dottie Brienza, Chief Diversity Officer and Executive Talent Leader, Merck said, "This award recognizes Merck's commitment to fostering an environment where all employees, including working parents and those who provide care for others, can effectively integrate work and life, take care of themselves and their families and reach their professional goals." The Full Research Report on Merck & Co. Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-23/MRK]

AbbVie Inc. Research Report

On September 19, 2013, AbbVie Inc. (AbbVie) announced that its Board of Directors has authorized a quarterly cash dividend of $0.40 per share to be payable on November 15, 2013, to stockholders of record at the close of the business on October 15, 2013. The Company stated that AbbVie, which was created in 2013 after being separated from Abbott, was selectedin the S&P Dividend Aristocrats Index, as a result of the Index's change in its treatment of spin-off companies. According to AbbVie, the S&P Dividend Aristocrats Index tracks companies that have annually increased their dividend for at least 25 consecutive years. The Full Research Report on AbbVie Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-23/ABBV]

HEALTHSOUTH Corp. Research Report

On September 12, 2013, HealthSouth Corp. (HealthSouth) announced that its Board of Directors has approved a quarterly cash dividend of $16.25 per share on its 6.5% Series A Convertible Perpetual Preferred Stock, payable on October 15, 2013, to holders of record on October 1, 2013. The Company also informed that in line with its previous announcement, the Board has also declared an initial quarterly cash dividend of $0.18 per share on its common stock, payable on October 15, 2013, to holders of record as on October 1, 2013. The Full Research Report on HEALTHSOUTH Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-23/HLS]

Quintiles Transnational Holdings Inc. Research Report

On September 9, 2013, Quintiles Transnational Holdings Inc. (Quintiles) announced that it has been awarded for its leadership in business technology innovation as it has been included in the InformationWeek 500 for the fifth consecutive year. According to the Company, over the period of past five years, InformationWeek has honored Quintiles for various industry leading business technology innovations across the drug development continuum. Quintiles stated that it has created an industry-wide platform, Infosario Safety, which addresses the challenges of managing drug safety to improve patient outcomes and drive compliance with changing regulatory requirements while enhancing quality and productivity across a product's lifecycle. Quintiles stated that InformationWeek identifies and recognizes the nation's most innovative users of information technology with its annual InformationWeek 500 listing, and also tracks the technology, strategies, investments and administrative practices of some of the best-known organizations in the country. The Full Research Report on Quintiles Transnational Holdings Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-23/Q]

The Ensign Group, Inc. Research Report

On September 19, 2013, The Ensign Group, Inc.(Ensign) announced that its Board of Directors has approved a quarterly cash dividend in the amount of c.$0.07 per share of Ensign common stock. According to the Company, the dividend is payable on or before October 31, 2013 to shareholders of record as on September 30, 2013. Ensign informed that it has been paying dividends since 2002. The Full Research Report on The Ensign Group, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-23/ENSG]

EDITOR NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
5. For any urgent concerns or inquiries, please contact us at [email protected].
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://www.InvestorsReports.com

SOURCE Investors' Reports